Improved diagnosis of cervical spondylotic myelopathy with contact heat evoked potentials by Jutzeler, Catherine et al.
Zurich Open Repository and
Archive
University of Zurich
Main Library
Strickhofstrasse 39
CH-8057 Zurich
www.zora.uzh.ch
Year: 2017
Improved diagnosis of cervical spondylotic myelopathy with contact heat
evoked potentials
Jutzeler, Catherine; Ulrich, Anett; Huber, Barbara; Rosner, Jan; Kramer, John; Curt, Armin
Abstract: The aim of this study was to reveal the sensitivity and responsiveness of contact heat evoked
potentials (CHEPs) to assess cervical spondylotic myelopathy (CSM). A total of 81 patients with clin-
ically and radiologically confirmed spinal cord compression were reviewed. All patients underwent full
clinical examinations with combined recordings of segmental CHEPs and somatosensory evoked poten-
tials (dSSEPs) compared to healthy controls. Cross-sectional area, maximal canal compression, and
maximal spinal cord compression were determined based on T2-weighted magnetic resonance images
(MRI). CHEPs exhibited the highest sensitivity ( 95%) to disclose at-level impairments in CSM patients.
Normally appearing rostral segments above the level of lesion were impaired in 17% of patients. Com-
paratively, dSSEPs were less affected (24%) and predominantly impaired at and below the level of CSM.
Longitudinal evaluation revealed that CHEPs progressively impaired in parallel with clinical deteriora-
tion. CHEPs were sensitive to CSM, revealing evidence of impaired neurophysiology at and below the
radiographic level of stenosis. The changes observed above the level of CSM suggest neurophysiological
deficits beyond the focally damaged area. Deteriorating CHEPs were observed in a cohort of patients
with worsening neurological symptoms, indicating their responsiveness to track CSM. The present study
highlights the value of incorporating CHEPs into the diagnosis and prognosis of CSM.
DOI: https://doi.org/10.1089/neu.2016.4891
Posted at the Zurich Open Repository and Archive, University of Zurich
ZORA URL: https://doi.org/10.5167/uzh-136396
Journal Article
Accepted Version
Originally published at:
Jutzeler, Catherine; Ulrich, Anett; Huber, Barbara; Rosner, Jan; Kramer, John; Curt, Armin (2017).
Improved diagnosis of cervical spondylotic myelopathy with contact heat evoked potentials. Journal of
Neurotrauma, 34(12):2045-2053.
DOI: https://doi.org/10.1089/neu.2016.4891
1 
Page 1 of 30 
 
Jo
u
rn
al
 o
f 
N
eu
ro
tr
au
m
a 
Im
p
ro
v
ed
 d
ia
g
n
o
si
s 
o
f 
ce
rv
ic
al
 s
p
o
n
d
y
lo
ti
c 
m
y
el
o
p
at
h
y
 w
it
h
 c
o
n
ta
ct
 h
ea
t 
ev
o
k
ed
 p
o
te
n
ti
al
s 
 (
d
o
i:
 1
0
.1
0
8
9
/n
eu
.2
0
1
6
.4
8
9
1
) 
T
h
is
 p
ap
er
 h
as
 b
ee
n
 p
ee
r-
re
v
ie
w
ed
 a
n
d
 a
cc
ep
te
d
 f
o
r 
p
u
b
li
ca
ti
o
n
, 
b
u
t 
h
as
 y
et
 t
o
 u
n
d
er
g
o
 c
o
p
y
ed
it
in
g
 a
n
d
 p
ro
o
f 
co
rr
ec
ti
o
n
. 
T
h
e 
fi
n
al
 p
u
b
li
sh
ed
 v
er
si
o
n
 m
ay
 d
if
fe
r 
fr
o
m
 t
h
is
 p
ro
o
f.
 
Improved diagnosis of cervical spondylotic myelopathy with contact 
heat evoked potentials  
Authors: Catherine R. Jutzeler, PhD; Anett Ulrich, MD; Barbara Huber, MSc; Jan 
Rosner; MD, John K.L. Kramer, PhD*; and Armin Curt, MD* 
 
Catherine R. Jutzeler: ICORD, University of British Columbia, Vancouver, British Columbia, Canada and 
Spinal Cord Injury Center, University Hospital Balgrist, Zurich, Switzerland 
Anett Ulrich: Spinal Cord Injury Center, University Hospital Balgrist, Zurich, Switzerland 
Barbara Huber: Spinal Cord Injury Center, University Hospital Balgrist, Zurich, Switzerland 
Jan Rosner: Spinal Cord Injury Center, University Hospital Balgrist, Zurich, Switzerland 
John LK Kramer: ICORD, University of British Columbia, Vancouver, British Columbia, Canada and 
School of Kinesiology, University of British Columbia, Vancouver, BC, Canada 
Armin Curt: Spinal Cord Injury Center, University Hospital Balgrist, Zurich, Switzerland 
 
*Shared last authorship 
 
 
Title character count: 90 
 
Number of references: 40 
Number of tables: 3 
Number of figures: 5 
 
 
Corresponding author: 
Catherine R. Jutzeler 
818 W 10th Ave 
Vancouver, BC, Canada 
V5Z 1M9 
Phone: +1-604-675-8876 
Catherine.Jutzeler@ubc.ca 
URL: www.icord.org 
 
 
Anett Ulrich: ulrich.anett@gmx.de 
Barbara Huber: Barbara.huber@balgrist.ch 
Jan Rosner: Jan.Rosner@balgrist.ch 
John Kramer: Kramer@icord.org 
Armin Curt: Armin.Curt@balgrist.ch 
 
 
 
 
Journal of Neurotrauma 
                        © Mary Ann Liebert, Inc.  
                        DOI: 10.1089/neu.2016.4891 
 Page 1 of 30 
Jo
ur
na
l o
f N
eu
ro
tra
um
a
Im
pr
ov
ed
 d
ia
gn
os
is 
of
 c
er
vi
ca
l s
po
nd
yl
ot
ic
 m
ye
lo
pa
th
y 
w
ith
 c
on
ta
ct
 h
ea
t e
vo
ke
d 
po
te
nt
ia
ls 
(do
i: 1
0.1
08
9/n
eu
.20
16
.48
91
)
Th
is 
ar
tic
le
 h
as
 b
ee
n 
pe
er
-re
vi
ew
ed
 a
nd
 a
cc
ep
te
d 
fo
r p
ub
lic
at
io
n,
 b
ut
 h
as
 y
et
 to
 u
nd
er
go
 c
op
ye
di
tin
g 
an
d 
pr
oo
f c
or
re
ct
io
n.
 T
he
 fi
na
l p
ub
lis
he
d 
ve
rs
io
n 
m
ay
 d
iff
er
 fr
om
 th
is 
pr
oo
f.
2 
Page 2 of 30 
 
Jo
u
rn
al
 o
f 
N
eu
ro
tr
au
m
a 
Im
p
ro
v
ed
 d
ia
g
n
o
si
s 
o
f 
ce
rv
ic
al
 s
p
o
n
d
y
lo
ti
c 
m
y
el
o
p
at
h
y
 w
it
h
 c
o
n
ta
ct
 h
ea
t 
ev
o
k
ed
 p
o
te
n
ti
al
s 
 (
d
o
i:
 1
0
.1
0
8
9
/n
eu
.2
0
1
6
.4
8
9
1
) 
T
h
is
 p
ap
er
 h
as
 b
ee
n
 p
ee
r-
re
v
ie
w
ed
 a
n
d
 a
cc
ep
te
d
 f
o
r 
p
u
b
li
ca
ti
o
n
, 
b
u
t 
h
as
 y
et
 t
o
 u
n
d
er
g
o
 c
o
p
y
ed
it
in
g
 a
n
d
 p
ro
o
f 
co
rr
ec
ti
o
n
. 
T
h
e 
fi
n
al
 p
u
b
li
sh
ed
 v
er
si
o
n
 m
ay
 d
if
fe
r 
fr
o
m
 t
h
is
 p
ro
o
f.
 
Abstract 
The aim of this study was to reveal the sensitivity and responsiveness of contact heat evoked 
potentials (CHEPs) to assess cervical spondylotic myelopathy (CSM). A total of 81 patients with 
clinically and radiologically confirmed spinal cord compression were reviewed. All patients 
underwent full clinical examinations with combined recordings of segmental CHEPs and 
somatosensory evoked potentials (dSSEPs) compared to healthy controls. Cross-sectional area, 
maximal canal compression, and maximal spinal cord compression were determined based on 
T2-weighted magnetic resonance images (MRI). CHEPs exhibited the highest sensitivity (~95%) 
to disclose at-level impairments in CSM patients. Normally appearing rostral segments above 
the level of lesion were impaired in 17% of patients. Comparatively, dSSEPs were less affected 
(24%) and predominantly impaired at and below the level of CSM. Longitudinal evaluation 
revealed that CHEPs progressively impaired in parallel with clinical deterioration.  CHEPs were 
sensitive to CSM, revealing evidence of impaired neurophysiology at and below the radiographic 
level of stenosis. The changes observed above the level of CSM suggest neurophysiological 
deficits beyond the focally damaged area. Deteriorating CHEPs were observed in a cohort of 
patients with worsening neurological symptoms, indicating their responsiveness to track CSM. 
The present study highlights the value of incorporating CHEPs into the diagnosis and prognosis 
of CSM.   
 
Key Words: Cervical Spondylotic Myelopathy, Contact heat evoked potentials, 
Prognosis and Diagnosis, Neurophysiological Assessment  
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Introduction 
 Cervical spondylotic myelopathy (CSM) is a common progressive degenerative disorder 
associated with static or dynamic compression of the spinal cord. In the initial stages of CSM, 
clinical neurological symptoms are typically mild (e.g., paresthesia), accompanied by minimal 
functional disability. However, progressive spinal cord compression can cause severe neurologic 
deterioration in ascending and descending pathways, which in turn leads to major long-term 
disability.[1-3] Surgical decompression is an effective strategy to ameliorate the neurological and 
functional consequences of CSM.[4-6] The success of surgery, however, depends on several 
factors, including early and accurate diagnosis.[7, 8] To evaluate structural abnormalities 
underlying patient reported symptoms, magnetic resonance imaging (MRI) represents a 
common diagnostic and prognostic tool.  
 The difficulty with relying on MRI alone is that a large proportion of otherwise healthy 
individuals (i.e., asymptomatic) present with some form of spinal cord compression.[9, 10] To 
complement the radiographic investigation, neurophysiological assessments have been 
employed to measure the functional integrity of the spinal cord. Most commonly, this involves 
electrical stimulation of mixed nerves (e.g., ulnar and tibial) or a cutaneous area (so-called 
“dermatomal”), and the acquisition of somatosensory evoked potentials (SSEPs or dSSEPs, 
respectively).[3, 11-13] As an objective measure of conduction in the dorsal columns, SSEPs have 
contributed to better prediction of long-term outcomes following surgery[3].   
 Recent studies have demonstrated the sensitivity of an alternative neurophysiological 
technique, so-called contact heat evoked potentials (CHEPs), to detect damage associated with 
spinal cord disorders. This prominently includes traumatic spinal cord injury and cases of 
syringomyelia.[14-16] In response to rapid heat stimuli, CHEPs reflect the recruitment of small 
diameter afferents in the periphery, decussation of second order neurons at (or near) the level of 
entry, afferent conduction in the spinothalamic tract, and, finally, cortical activation in brain areas 
involved in nociception.[17] The sensitivity of CHEPs compared to SSEPs is purportedly related 
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to physiologically greater axial coverage of the central spinal cord area (gray and white matter), 
as well as the anterolateral position of the spinothalamic tract.[18] The later may render CHEPs 
particularly sensitive to detect ischemic insults to the spinal cord arising due to occlusion of the 
anterior spinal cord artery.[19] Surprisingly, the application of CHEPs in CSM has not been 
previously examined. Additionally, few studies to date have provided evidence that CHEPs are 
responsive to longitudinal changes in pathology over time.  
 The overall aim of this study was to assess the sensitivity of CHEPs to reveal signs of 
spinal cord impairment in patients suspected to suffer from CSM. We hypothesized, based on 
greater anatomical coverage and anterolateral position of the spinothalamic tract, that CHEPs 
would exhibit superior sensitivity compared to a conventional neurophysiological approach (i.e., 
SSEPs). A secondary aim was to examine changes in CHEPs over time in patients with 
persistent or worsening neurological conditions. Here we hypothesized that CHEPs would 
deteriorate over time, corresponding with patient reported symptoms. To address our aims, we 
reviewed a large number of patients with radiologically and clinically confirmed CSM assessed 
with CHEPs.   
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Material and Methods 
Patients 
 A single-center retrospective study was conducted at the Spinal Cord Injury Center, 
University Hospital Balgrist in Zurich, Switzerland. The study includes patients with clinical 
symptoms of CSM that was confirmed by radiographic evidence of spinal cord compression, 
who were referred to our outpatient clinic between January 2009 and January 2016. Patients 
with any level (within cervical cord) and varying severity of CSM were included. Any patient with 
ossification of posterior longitudinal ligament, radiculopathy, diabetes mellitus, and a history of 
spinal tumor was excluded from the study. In addition, 50 age- and sex-matched healthy 
individuals were recruited between October 2015 and January 2016 in order for the acquisition 
of control values. These subjects were specifically examined to determine objective criteria to 
evaluate CHEPs. Exclusion criteria for the healthy cohort included intake of medication, 
presence of any neurological disorder, presence of pain, and pregnancy. All healthy individuals 
and patients provided written informed consent and all procedures described below were in 
accordance with the Declaration of Helsinki and approved by the local ethics board ‘Kantonale 
Ethikkommission Zürich, KEK’ (ref. number: EK-04/2006). 
Clinical assessments 
 Prior to the neurophysiological assessments, all patients were thoroughly examined by a 
trained physician according to the International Standards for Neurological Classification of 
Spinal Cord Injury (ISNCSCI) published by the American Spinal Injury Association (ASIA).[20-
23] This examination was applied to determine sensory, motor, and neurological levels of injury, 
as well as the severity of injury (i.e., completeness). Two aspects of sensation, light touch and 
pinprick (sharp-dull discrimination), were tested at predefined skin areas for the dermatomes C3-
Th1 and classified on a scale of 0-2 (i.e., 0 = absent, 1= impaired, 2=normal). Furthermore, the 
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physician assessed the presence of disease-characterizing symptoms including pain or stiffness 
in the neck, clumsiness in the hands, tingling or numbness in extremities, muscle weaknesses, 
gait disturbances, as well as  bladder and bowel dysfunction. 
Neurophysiological assessments 
 CHEPS and dSSEP were acquired from dermatomes above, at, and below the level of 
MRI-defined level of CSM with patients in the supine position. For the CHEPs recording, we 
used the same methodology as the one employed in previous studies.[24, 25] 
 Dermatomal SSEPs were elicited through repetitive electrical stimulation (repetitive 
square wave impulse of 0.5-millisecond duration) of the dermatome using self-adhesive bipolar 
stimulation electrodes and the Keypoint recording device (Medtronic, Minneapolis, MN). 
Stimulation frequency was set at 3.1 Hz and two traces of 200 stimulations were applied per 
dermatome. The stimulation intensity was individually set at 5-fold electrical perception 
threshold. Cortical responses (N1P1) were recorded from the contralateral scalp (C3’-C4’ in a 
10-20 electrode configuration, referenced to Fz) to the C4, C6, and C8 dermatomes being 
stimulated using needle electrodes (12 mm; Spes Medica s.r.l., Battipaglia, Italy).[13] Electrode 
impedance was kept below 5kΩ, which was verified prior to the initiation of each session and all 
signals were sampled at 10 kHz and bandpass filtered 2 Hz to 2 kHz. Averaged dSSEPs were 
visually inspected for N1 and P1 latencies. 
Neuroimaging: Acquisition and analysis  
 Spinal MRI of the whole cervical spine was performed in all patients included in the study 
(3T tesla; Siemens Medical Systems, Erlangen, Germany). CSM was diagnosed in all patients 
based on the clinical examination in conjunction with T1- and T2-weighted MRI images. CSM 
was defined as “MRI showing spinal stenosis and cord compression as a result of osteophyte 
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overgrowth, disc herniation, or ligamentum hypertrophy” and formally diagnosed by a trained 
radiologist.[1]  
 Prior to analysis the MRI data were screened for movement artefacts. From each MRI, 
the maximum canal compromise (MCC) and maximum spinal cord compression (MSCC) was 
identified radiologically as previously described.[26, 27] Using the midsagittal slice of T2-
weighted images, the anteroposterior canal diameter at the level of maximum compromise 
(stenosis) was compared with the anteroposterior canal diameter at the normal levels 
immediately above and below the level of stenosis. To quantify the degree of maximum canal 
compromise the following ratio was calculated: MCC= canal diameter at stenosis / (canal 
diameter above + canal diameter below). Similarly, the maximum spinal cord compression 
(MSCC) was measured (at the same level as maximum canal compromise) and calculated. In 
case of multi-segmental compression (n=6), the canal diameter of the normal levels was 
measured immediately above and below the last level of stenosis. 
 Furthermore, the signal change ratio was determined according Nouri.[28] Briefly, the 
region of hyperintensity or, if not applicable, from the level of greatest cord compression was 
compared against an average reference on the spinal cord at C7/T1 and C2 using T2 weighted 
images. Lastly, the cross-sectional spinal cord area was measured using a well-established 
semi-automated segmentation method.[29-31] Ten contiguous 2.75 mm axial slices were 
reformatted using the center of C2/C3 intervertebral disc as a caudal landmark, with the slices 
perpendicular to the spinal cord. All analyses were performed using JIM 7.0 (Xynapse Systems, 
Aldwincle, UK).  
Control values 
 Contact heat evoked potentials, pin prick, and light touch testing was unilaterally 
performed in the dermatomes C4, C6, and C8. For the dSSEPs, controls values were taken from 
a previous study of our group (see Table 1).[32] 
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Interpretation of dSSEPs and CHEPs 
 Averaged dSSEPs were visually inspected for N1 and P1 latencies and classified as 
having (1) a normal N1 latency (within +2 standard deviations [SD]), (2) a delayed N1 latency 
(≥+2SD of mean control values), or (3) an absent N1 latency. The interpretation of the CHEPs 
was based on the visual inspection of the average waveform for N2 and P2 latencies and 
amplitudes. The classification comprised of five the categories normal (5), low amplitude and 
normal latency (4), normal amplitude and delayed latency (3), low amplitude and delayed latency 
(2), and absent CHEPs (1). The control values from healthy subjects served as reference for the 
classification. Both, N2 latency and N2P2 amplitude, were classified as impaired when the 
values were lying outside the range of healthy controls.  
 
Statistical analysis 
 Non-parametric tests were applied to determine significant differences CHEP N2 and P2 
latencies, and N2P2 amplitudes between healthy controls and patients with CSM for each 
dermatome (i.e., C4, C6, and C8). The patient’s cohort was divided into two groups, specifically 
(a) above MRI level of lesion (i.e., dermatome analyzed is above the MRI lesion) and (b) 
at/below MRI level of lesion (i.e., dermatome analyzed is at or below the MRI lesion). 
  The sensitivity of CHEPs, dSSEPs, PP, and LT to detect CSM was compared to the 
conventional diagnosis of CSM, including clinical and imaging assessments (i.e., “golden 
standard”). To account for unequal number of patients that underwent dSSEP, CHEPs, and 
clinical testing, only patients who underwent all measurements were included (N=59). The 
presence of CSM was correctly determined if any of the examined dermatome indicated 
alterations (i.e., impaired or abolished function). This was done for all measurement techniques 
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separately. A confidence interval of a proportion analysis was conducted for each dermatome 
tested and level of CSM lesion (C3 to C6) to identify the proportions of detected CSM-related 
alterations by means of CHEPs. The classifications of the outcome of CHEPs were 
dichotomized into the two categories ‘normal’ and ‘impaired/abolished’. Proportions and 
confidence intervals of total measured dermatome and number of successful detections of CSM 
(i.e., impaired and abolished) were calculated.  
 Receiver operating characteristic (ROC) curve analysis was performed to further 
evaluate the sensitivity and specificity of CHEPs parameters (i.e., N2 latency and N2P2 
amplitude) for each dermatome. All healthy controls and CSM patients, independent of their 
level of lesion, were included in the analysis. In order to include patients with abolished CHEPs 
in the ROC analysis, an arbitrary value of 600ms was imputed for their N2 latency. This value 
was chosen, as we did not expect any cortical waveforms beyond 600ms. The amplitude of an 
abolished waveform was set to 0. The area under the ROC curve (AUC) was calculated as an 
index marker for the diagnostic accuracy. A diagnostic test is typically considered clinically 
useful if the AUC value exceeds 0.75.[33] 
 All statistical analyses were performed using IBM`s Statistical Package for the 
SocialSciences (SPSS) version 19.0 (Armonk, New York, U.S.). All Bonferroni correction was 
used to account for multiple comparisons. Statistical significance was set at α = 0.05. 
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Results 
Demographics, clinical assessments, and MRI findings 
 Out of 91 reviewed patients with CSM, 10 had to be excluded from the statistical analysis 
due to missing or not interpretable data (e.g., movement artefacts in MRI). The remaining 81 
patients were comprised of 52 males and 29 females with a mean age of 53.1 ± 15.2 years 
(range from 19 to 85 years). All patients were ambulatory (AIS impairment scale D (n = 66) or E 
(n = 15). Patients classified as AIS E (i.e., normal sensory and motor function according to 
ISNCSCI) presented with symptoms including pain and/ or stiffness of the neck (n=9), bladder 
problems (n=10), clumsiness of the hands (n=5), and balance problems (n=3).The level of CSM 
determined by the MRI ranged from C3 to C8 (C3 (n=12, 14.8%), C4 (n=22, 26.2%), C5 (n=21, 
25.9%), C6 (n=23, 28.4%), C7 (n=2, 2.5%), and C8 (n=1, 1.2%)). The healthy control cohort 
consisted of 35 male and 15 female individuals (mean age 51.8 ± 9.9, range from 19 to 80 
years). The characteristics of all individuals (i.e., patients and controls) are summarized in Table 
1. In patients, the maximum spinal cord compression (MSCC) was 18.2  ±  12.5% and 
maximum canal compromise (MCC) 27.9  ±  12.4%, which is comparable to previous 
findings.[34] In 33 patients a T2 signal hyperintensity with a signal change ratio of 1.25  ±  0.26 
was detected. The mean cross-sectional spinal cord area (SCA) at level C2 was 
72.1  ±  6.6mm2 (range 50.5-81.5), which is significantly smaller compared to previously 
reported values of healthy control cohorts.[31, 34, 35]  
Contact heat evoked potentials 
 In patients, CHEPs were assessed in 484 dermatomes (average number of dermatomes 
measured =4.8 +/- 1.9). The mean (±standard deviation) pain rating, N2 latency, and N2P2 
amplitude of CHEPs from healthy individuals for each dermatome are summarized in Table 2. 
54% (n=261) of recordings were within segments above the MRI level of lesion. Reduced N2P2 
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amplitudes and delayed N2 latencies were observed for dermatomes located above and 
at/below the level of lesion compared to the healthy cohort. Independent of lesion level, C4, C6, 
and C8 CHEPs were impaired or abolished in 41.5% [95% CI: 0.33-0.52], 73.2% [95% CI: 0.64-
0.81], and 77.9% [95% CI: 0.69-0.85] of CSM patients, respectively. The breakdown by lesion 
level is shown in Figure 1. 
 The ROC analysis revealed high diagnostic accuracy for C4, C6, and C8 CHEPs N2 
latency and N2P2 amplitude to discriminate CSM compared to healthy age-matched controls 
(Figure 2). Area under the curve (AUC) increased from C4 to C8 for both amplitude and latency. 
The areas under the ROC curve (AUC) for CHEPS N2P2 amplitude and N2 latency tested at C4 
dermatome to discriminate CSM vs no CSM were and 0.771 (95% CI, 0.695-0.848, p<0.001), 
respectively. For C6 and C8 dermatomes, the AUCs for N2P2 amplitude were 0.814 (95% CI, 
0.753-0.874, p<0.001) and 0.837 (95% CI, 0.776-0.898), respectively, and N2 latency 0.852 
(95% CI, 0.796-0.907, p<0.001) and 0.889 (95% CI, 0.835-0.943), respectively. 
Comparison of CHEPs, dSSEP, and clinical testing sensitivity 
 In patients examined with CHEPs, dSSEPs, and LT/PP (n=59), CHEPs showed the 
highest sensitivity to detect radiographic evidence of CSM (94.9%, n=56; Figure 3), followed by 
pinprick (72.9%, n=43), dSSEPs (23.7%, n=14), and light touch (23.7%, n=14).  
 
Follow up measures in CSM 
 In reviewing the entire CSM cohort, we identified 13 patients who underwent annual 
follow-up assessments for one or two years post initial diagnosis. The characteristics of these 13 
patients (mean age 45.7 ± 12.9 years, 3 female and 10 male) are summarized in Table 3. 10 
patients (3 female) experienced deteriorating neurological symptoms associated with CSM, 
including paraesthesia, hypersensitivity, and pain (n=6), muscle weakness/clumsiness (n=3), 
gait disturbances (n=3), and bladder problems (n=3). No changes were evident according to MRI 
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(MSCC, SCC, and hyperintensity ratio), dSSEPs, LT, or PP. Based on our classification of 
CHEPs, all 10 patients experiencing worsening symptoms demonstrated objective evidence of 
deterioration (i.e., increased latency, reduced amplitude) above, at, and/or below the level of 
injury (Figure 4). In the 3 patients with stable CSM symptoms, CHEPs did not change over time. 
   
Discussion 
 In the present study, we have provided evidence that CHEPs are highly sensitive to 
detect spinal cord impairment related to CSM. Impaired CHEPs were evident in those spinal 
cord segments that corresponded with obvious signs of myelopathy (i.e., at- and below-level), as 
well as seemingly unaffected rostral segments. Comparatively, the sensitivity of clinical testing 
(i.e., pin prick and light touch) and dSSEP was limited to spinal segments at or caudal to the 
radiographic level of stenosis. Longitudinal evaluation of 13 patients found that worsening 
neurological symptoms (n=10) were accompanied by deteriorating CHEPs (Figure 4). 
Importantly, deterioration was apparent in dermatomes above, at-, and below the radiographic 
level of stenosis. Collectively, these observations highlight focal (i.e., at level of stenosis), as well 
as extended pathology (i.e., rostral and caudal to stenosis) related to CSM and a greater 
sensitivity to detect CSM using CHEPs. 
Sensitivity of CHEPs  
 Previous studies demonstrate that CHEPs are sensitive to detect a variety of spinal cord 
impairments, including severe cord damage (i.e. post traumatic cyst and syrinx formation) and 
spinal cord syndromes (i.e. anterior and central cord syndromes).[14] Their advantage, 
compared to other neurophysiological techniques (e.g., dSSEPs), is a unique ability to detect 
pathology in both affected and ‘normal appearing’ spinal segments (i.e., rostral to the level of 
injury). Differences in underlying anatomy (somato-topic organization of spinal tracts including 
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fiber decussation) and vulnerability to ischemia (central cord area is highly susceptible to 
impairment of blood supply) may explain, in part, the higher sensitivity of CHEPs to detect CSM 
(Figure 5A). As a function of small diameter afferents decussating upon entry into the spinal 
cord, CHEPs are particularly well suited to detect pathology in central gray matter. In contrast, 
SSEPs enter the spinal cord and project cortically via the dorsal columns without decussation 
and higher collateral vascularization. Consequently, SSEPs only reflect pathology in dorsal and 
dorsolateral regions of the spinal cord. CHEPs may also be more sensitive because of the 
position of the spinothalamic tract relative to the dorsal columns and the tendency for CSM to 
emerge in the anterior regions of the spinal cord.[36, 37]  
  
Functional and structural changes rostral to the level of lesion 
 What appears to be most interesting about CHEPs is the detection of impairment in 
“normally appearing” spinal segments above the level of stenosis. As illustrated in Figure 5B, 
17% of examined dermatomes rostral to the level of stenosis, without any obvious sign of 
impairment, showed altered or even abolished CHEPs. These changes in amplitude and latency 
may reflect a form of extended myelopathy, which occurs secondary to the direct mechanical 
trauma caused by spinal cord compression (i.e., focal myelopathy at the level of CSM, see 
Figure 5C). Alternatively, emerging evidence suggests that CSM results in changes along the 
entire neuro-axis (Figure 5D). Since CHEPs are ultimately a reflection of cortical processing, 
their impairment may also reflect changes in the brain,[38, 39] where cortical reorganization 
alters the pattern of activity for processing noxious heat stimuli, yielding reductions in amplitude 
and shifts in latency.  
 
 
 
 
 Page 13 of 30 
Jo
ur
na
l o
f N
eu
ro
tra
um
a
Im
pr
ov
ed
 d
ia
gn
os
is 
of
 c
er
vi
ca
l s
po
nd
yl
ot
ic
 m
ye
lo
pa
th
y 
w
ith
 c
on
ta
ct
 h
ea
t e
vo
ke
d 
po
te
nt
ia
ls 
(do
i: 1
0.1
08
9/n
eu
.20
16
.48
91
)
Th
is 
ar
tic
le
 h
as
 b
ee
n 
pe
er
-re
vi
ew
ed
 a
nd
 a
cc
ep
te
d 
fo
r p
ub
lic
at
io
n,
 b
ut
 h
as
 y
et
 to
 u
nd
er
go
 c
op
ye
di
tin
g 
an
d 
pr
oo
f c
or
re
ct
io
n.
 T
he
 fi
na
l p
ub
lis
he
d 
ve
rs
io
n 
m
ay
 d
iff
er
 fr
om
 th
is 
pr
oo
f.
14 
Page 14 of 30 
 
Jo
u
rn
al
 o
f 
N
eu
ro
tr
au
m
a 
Im
p
ro
v
ed
 d
ia
g
n
o
si
s 
o
f 
ce
rv
ic
al
 s
p
o
n
d
y
lo
ti
c 
m
y
el
o
p
at
h
y
 w
it
h
 c
o
n
ta
ct
 h
ea
t 
ev
o
k
ed
 p
o
te
n
ti
al
s 
 (
d
o
i:
 1
0
.1
0
8
9
/n
eu
.2
0
1
6
.4
8
9
1
) 
T
h
is
 p
ap
er
 h
as
 b
ee
n
 p
ee
r-
re
v
ie
w
ed
 a
n
d
 a
cc
ep
te
d
 f
o
r 
p
u
b
li
ca
ti
o
n
, 
b
u
t 
h
as
 y
et
 t
o
 u
n
d
er
g
o
 c
o
p
y
ed
it
in
g
 a
n
d
 p
ro
o
f 
co
rr
ec
ti
o
n
. 
T
h
e 
fi
n
al
 p
u
b
li
sh
ed
 v
er
si
o
n
 m
ay
 d
if
fe
r 
fr
o
m
 t
h
is
 p
ro
o
f.
 
Responsiveness of CHEPs 
 While previous studies have demonstrated the utility of CHEPs to detect damage in the 
spinal cord,[14] none have examined the natural course (in the absence of surgery) over time. In 
order to better understand the course of in CSM with either stable findings or slow progression, a 
recent review has pointed out the need for such investigation.[40] The longitudinal analysis of 13 
patients demonstrates a very strong association between neurophysiology and symptomology 
(Figure 4). As illustrated in Figure 4, CHEPs deteriorated progressively, spreading from the level 
of stenosis to rostral and adjacent spinal segments in 10 patients with worsening neurological 
symptoms. Indicating high sensitivity and specificity to detect CSM, CHEPs remained stable in 
the remaining 3 subjects that did not report any change in their neurological condition (Table 3). 
Compared to these robust changes in CHEPs, conventional MRI (i.e., T1 and T2 weighted 
images) did not yet track patients’ deteriorated neurological symptoms. Although limited by a 
small sample size (n=10), these observations point to the need for a multi-modal assessment of 
CSM, coupling MRI with electrophysiology to track meaningful changes in spinal cord function. 
This may be particularly important in the early stage of CSM, where MRI alone does not yet 
reveal evidence of pathology (compared to age-matched healthy individuals). Furthermore, 
based on this knowledge, CHEPs could serve as a useful tool to investigate the efficacy of 
interventions (surgical or non-surgical) to prevent the progression of CSM.  
    
Limitation and Future Directions 
 The retrospective nature of the study represents a notable limitation. Of concern, only 
clinically assumed CSM patients were reviewed, which may have led to a selection bias. A 
prospectively designed longitudinal study involving a range of patients with and without CSM 
measured with MRI and CHEPs is warranted to address this limitation. In this retrospective 
study, the clinical assessment was based on using the ISNCSCI protocol which is an 
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international standardized and accepted clinical assessment tool in traumatic spinal cord 
disorders. Future studies need also to  employ the Japanese Orthopedic Association (JOA) 
score as it represents nowadays the standard to assess the severity of clinical symptoms in non-
traumatic  CSM patients. The sample size of our longitudinal study is relatively small, which 
limits statistical power. Nevertheless, it is the first longitudinal study tracking functional changes 
by means of CHEPs without any surgical intervention. To assess the extent and the specific 
level of CSM, adjustments to the current CHEPs protocol are needed. Most notably, the analysis 
of contact heat stimulation will benefit from assessing several cervical levels. Lastly, future 
studies should consider the effect of surgical (or non-surgical) intervention on CHEPs, in order to 
determine their responsiveness to treatment and prediction of recovery. In turn, this will improve 
the decision making process during treatment planning.  
 
Conclusion 
 
 The present study highlights the sensitivity and responsiveness of CHEPs in patients 
with CSM. Corresponding with radiographic evidence, pathological CHEPs were evident at the 
level of CSM. For the first time, we present data that suggests sub-clinical pathology in rostral 
“normal” appearing spinal segments. Importantly, these changes were observed to occur over 
time, progressing from the level of stenosis into adjacent rostral spinal segments. Overall, our 
observations strongly highlight the potential value of incorporating CHEPs into the diagnosis of 
CSM.  
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Figure Legend: 
 
 
 
Figure 1: Percentage of pathological CHEPs according to tested dermatomes. Independent 
of the MRI level of CSM, testing dermatome C8 or C6 yielded the highest proportion of 
pathological (i.e. impaired or abolished) CHEPs. Conclusively, acquiring CHEPs from C8 or C6 
(i.e., likely located below the level of CSM according to MRI) will be most sensitive to indicate 
spinal cord impairment in CSM. 
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Figure 2: ROC Curve analysis for N2 latency and N2P2 amplitude measured in dermatome 
C4, C6, and C8. Both, N2 latency and N2P2 amplitude showed high diagnostic accuracy to 
discriminate CSM vs no CSM. As expected, the lowest AUC (0.641) was found for both 
measures acquired from dermatome C4 as also patients with CSM level below C4 (i.e., C4 
dermatome was arguably unaffected) were included in the analysis.  
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Figure 3: Sensitivity of clinical sensory testing, contact heat evoked potentials, and 
dermatomal SSEPs in CSM. In all enrolled patients, there was radiological evidence (i.e. signs 
of cord compression) for an existing CSM. Overall, CHEPs showed the highest sensitivity to 
detect CSM in comparison to dermatomal SSEPs (dSSEP), pin prick, and light touch testing. 
The bars represent the percentage of patients with at least one impaired dermatome above, at, 
or below the level of CSM measured by means of CHEPs, dSSEP, pinprick, or light touch. 
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Figure 4: Responsiveness of CHEPs. (A) At the initial examination (baseline) this CSM patient 
showed first signs of impairment (i.e., reduced amplitude and delayed latency) in CHEPs in 
dermatome C8, while C4 and C6 were still normal. In one year time with increasing clinical 
symptoms, CHEPs in C8 became abolished and altered in C6 (i.e., reduced amplitude and 
delayed latency), while remained normal in C4. At the 2-year follow up with seriously worsened 
clinical condition CHEPs of all dermatomes were abolished. The changes in CHEPS are in line 
with the aggravation of clinical symptoms. (B) This patient had no change in the clinical 
symptoms and radiological evidence over time and CHEPs remained unchanged. (C) Summary 
figure of changes in CHEPs classification over time in 13 CSM patients. Three patients had no 
changes in clinical symptoms and no change in CHEPs (dotted lines). The remaining 10 
experienced aggravation of their clinical symptoms and a decline in the CHEPs classification 
(characteristics of the patients are summarized in Table e-2. 
Green: Normal CHEP (i.e., normal amplitude and normal latency) 
Yellow: Impaired CHEPs (i.e., reduced amplitude and delayed latency) 
Red: Abolished CHEP 
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Figure 5: (A) The somato-topical organization of dorsal column tracts and spino-thalamic 
pathways underlay the specific sensitivity of CHEPs in central cord pathology superior to SSEP. 
(B) CSM is defined by incomplete central cord damage and impaired CHEPs can be revealed 
rostral, at, and below the level of CSM. (C) Spinal cord compression leads to damage expanding 
from the primary focal level of compression in both the rostral and caudal directions into adjacent 
spinal segments. In contrast to conventional MRI or clinical testing, advanced MRI techniques 
(spinal cord area, cord compression measures) and neurophysiological assessments (i.e., 
CHEPs) allow the detection of the damage in rostral spinal segments. (D) Despite originating 
spinally, the consequences of CSM are evident along the entire neuro-axis (i.e., spinal cord and 
brain). As such, cerebral reorganization might be involved in the impairment of CHEPs above 
the level of lesion.  
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Parameter 
Groups 
 Healthy controls CSM Patients 
Gender [male : female] 35:15 52 : 29 
Age [yrs] 51.8 ± 9.9 53.1 ± 15.2 
Height [cm] 172.3 ± 18.4 171.8 ± 13.9 
ASIA Score (D:E)* 0:50 66 : 15 
Duration of CSM [yrs]  2.4 ± 3.0 
MRI level of injury (C3:C4:C5:C6:C7:C8)  12:22:21:23:2:1 
Table 1. Demographic and clinical details of the study cohorts  
 
 
Results are displayed as mean ± standard deviation. 
 
*ASIA Score: D, motor function is preserved below the neurological level, and at least 
half of the key muscles below the neurological level have a muscle grade of > 3. E: 
Normal motor and sensory function 
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Group 
Significant pairwise comparisons
‡
 
Controls 
1
CSMabove  
2
CSMat/below 
Contact heat evoked potentials  
C4 Dermatome     
 
N2 Latency [ms] 363.9 ± 27.9 394.7 ± 40.5 400.7 ±61.8 Controls – CSMabove (p=0.002), Controls – CSMat/below (p=0.028) 
N2P2 Amplitude [µV] 24.5 ± 9.4 23.3 ± 13.7 21.0 ± 14.0 
ns 
Pain rating (NRS) 5.7 ± 1.9 4.5 ± 2.5 4.3 ± 2.1 
ns 
C6 Dermatome  
 
 
N2 Latency [ms] 386.8 ± 27.4 443.1 ± 44.0 423.7 ± 58.5  Controls – CSMabove (p=0.002), Controls – CSMat/below (p<0.001) 
N2P2 Amplitude [µV] 22.5 ± 6.9 14.8 ± 8.4 17.8 ± 8.9  Controls – CSMabove (p<0.007), Controls – CSMat/below (p=0.004) 
Pain rating (NRS) 4.9 ± 1.7 3.4 ± 2.4 4.3 ± 2.2  ns 
C8 Dermatome  
 
N2 Latency [ms] 404.6 ± 25.9 421.5 ± 38.5 428.5 ± 58.8  Controls – CSMat/below (p=0.023) 
N2P2 Amplitude [µV] 20.8 ± 6.9 20.1 ± 10.1 18.0 ± 8.4  Ns 
Pain rating (NRS) 4.5 ± 1.8 2.9 ± 2.8 3.7 ± 2.3  Ns 
Dermatomal somatosensory evoked potentials  
C4 Dermatome N1 Latency [ms] 14.3 ± 2.5* 14.7 ± 5.6 16.1 ± 3.2  ns 
C6 Dermatome N1 Latency [ms] 24.3 ± 2.4* 23.6 ± 8.2 28.1 ± 2.6  Controls – CSMat/below (p=0.041) 
C8 Dermatome N1 Latency [ms] 24.6 ± 2.1* 26.1 ± 9.2 27.1 ± 6.3  Controls – CSMat/below (p=0.039) 
 
Results are displayed as mean ± standard deviation. 
 
1
CSMabove: Above the MRI level of lesion 
2
CSMat/below: At/ below the MRI level of lesion 
 
Table 2: Contact heat and dermatomal SSEP parameters 
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*:   Reference values are taken from Kramer et al., 2010 
‡: Bonferroni corrected 
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ID Age Gender Time since 
injury [yrs] 
Level of lesion CHEPs Parameters at 
1 year follow-up  
MRI measures at 1 year 
follow-up 
Progression of CSM 
P01 35 F 2 C6/7 
Delayed N2 Latency 
and reduced N2P2 
Amplitude 
MCC and MSCC ↑, SCA 
↓ Aggravation: Clumsiness in hand 
P02 41 F 3 C4 
Abolished CHEPs MCC and MSCC ↑, SCA 
↓ 
Aggravation: Development of pain and paresthesia 
P03 65 F 2 C5/6 
Abolished CHEPs No change in MCC and 
MSCC, SCA ↓ 
Aggravation: Development of pain, paresthesia, 
and incontinence 
P04 69 M 4 C6/7 
Delayed N2 Latency 
and reduced N2P2 
Amplitude 
MCC and MSCC ↓, no 
change in SCA 
Aggravation: Development of pain, bladder 
problems 
P05 57 M 3 C5/6 
No change in N2P2 
amplitude and N2 
Latency 
MCC and MSCC ↑, no 
change in SCA Stable: No change in symptoms 
P06 37 M 3 C5/6 
Abolished CHEPs No change in MCC and 
MSCC, SCA ↓ 
Aggravation: Gait disturbances 
P07 32 M 2 C3/C4 
Abolished CHEPs MCC and MSCC ↑, SCA 
↓ 
Aggravation: Development of pain and bladder 
problems, decline of sensory function 
P08 60 M 3 C6 
Abolished CHEPs No change in MCC, 
MSCC, and SCA 
Aggravation: Gait disturbances, clumsiness of 
hands, development of pain 
P09 39 M 3 C6/7 
No change in N2P2 
amplitude and N2 
Latency 
MCC and MSCC ↓ 
Stable: No change in symptoms 
P10 32 M 2 C6 
Delayed N2 Latency MCC and MSCC ↓, no 
change in SCA 
Aggravation: Muscle weakness in both hands, 
incontinence 
P11 51 M 4 C5/6 
Delayed N2 Latency 
and reduced N2P2 
Amplitude 
MCC and MSCC ↓, SCA 
↓ Aggravation: Development of pain 
P12 62 M 3 C5 
No change in N2P2 
amplitude and N2 
Latency 
MCC and MSCC ↑, SCA 
↓ Stable: No change in symptoms 
P13 38 M 2 C5 
Delayed N2 Latency No change in MCC and 
MSCC, no change in SCA 
Aggravation: Gait disturbances, clumsiness of 
hands, development of pain 
Table 3: Clinical and demographic details of the longitudinal patients cohort 
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MCC: Maximal Canal Compression 
MSCC:  Maximal Spinal Cord Compression 
SCA: Spinal Cord Area 
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